Archive - July 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For Evenity (romosozumab) To The US FDA
FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox
The Clock is Ticking: How to Speed up Efforts to Meet Traceability Deadlines
Bringing Smart Instrumentation to Life Sciences
Put your agency in the spotlight, ENTER NOW
Recognising the outstanding achievements of medical and scientific professionals
May’s Brexit plan cautiously welcomed by biopharma sector
Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks ‘soft Brexit’ plan